Eligard 45 mg Polvere e Solvente per la Produzione di un Deposito-Sospensione iniettabile 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

eligard 45 mg polvere e solvente per la produzione di un deposito-sospensione iniettabile

recordati ag - leuprorelini acetas - polvere e solvente per la produzione di un deposito-sospensione iniettabile - praeparatio cryodesiccata: leuprorelini acetas 45 mg pro vitro. solvens: poly(lactidum-co-glycolidum) 85/15, n-methylpyrrolidonum, pro vitro. - sintetico del gnrh analogo in caso di carcinoma prostatico - synthetika

Lutrate Depot i.m. 3.75 mg poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

lutrate depot i.m. 3.75 mg poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie

labatec pharma sa - leuprorelinum - poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie - poudre: leuprorelini acetas 3.75 mg corresp. leuprorelinum 3.57 mg, poly(lactidum-co-glycolidum), triethylis citras, mannitolum, carmellosum natricum corresp. natrium 1.3 mg, polysorbatum 80, pro vitro. solvens: mannitolum, acidum hydrochloridum ad ph, natrii hydroxidum ad ph, aqua q.s. ad solutionem pro 2 ml. - il carcinoma della prostata - synthetika

Lutrate Depot i.m. 22.5 mg poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

lutrate depot i.m. 22.5 mg poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie

labatec pharma sa - leuprorelinum - poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie - poudre: leuprorelini acetas 22.5 mg corresp. leuprorelinum 21.42 mg, acidum polylacticum, triethylis citras, mannitolum, carmellosum natricum corresp. natrium 2.2 mg, polysorbatum 80, pro vitro. solvens: mannitolum, acidum hydrochloridum ad ph, natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - il carcinoma della prostata - synthetika

Degarelix Accord 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

FLUTAMIDE HEXAL 30CPR 250MG 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

flutamide hexal 30cpr 250mg

sandoz spa - flutamide - compresse - "250 mg compresse" 30 compresse

ARIMIDEX 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

arimidex

laboratoires juvise pharmaceuticals - anastrozolo - anastrozolo